A DNA base-specific sequence interposed between CRX and NRL contributes to RHODOPSIN expression

Rosa Maritato,Alessia Medugno,Emanuela D'Andretta,Giulia De Riso,Mariangela Lupo,Salvatore Botta,Elena Marrocco,Mario Renda,Martina Sofia,Claudio Mussolino,Maria Laura Bacci,Enrico Maria Surace
DOI: https://doi.org/10.1038/s41598-024-76664-8
IF: 4.6
2024-11-03
Scientific Reports
Abstract:Gene expression emerges from DNA sequences through the interaction of transcription factors (TFs) with DNA cis -regulatory sequences. In eukaryotes, TFs bind to transcription factor binding sites (TFBSs) with differential affinities, enabling cell-specific gene expression. In this view, DNA enables TF binding along a continuum ranging from low to high affinity depending on its sequence composition; however, it is not known whether evolution has entailed a further level of entanglement between DNA-protein interaction. Here we found that the composition and length (22 bp) of the DNA sequence interposed between the CRX and NRL retinal TFs in the proximal promoter of RHODOPSIN ( RHO ) largely controls the expression levels of RHO. Mutagenesis of CRX-NRL DNA linking sequences (here termed "DNA-linker") results in uncorrelated gene expression variation. In contrast, mutual exchange of naturally occurring divergent human and mouse Rho cis -regulatory elements conferred similar yet species-specific Rho expression levels. Two orthogonal DNA-binding proteins targeted to the DNA-linker either activate or repress the expression of Rho depending on the DNA-linker orientation relative to the CRX and NRL binding sites. These results argue that, in this instance, DNA itself contributes to CRX and NRL activities through a code based on specific base sequences of a defined length, ultimately determining optimal RHO expression levels.
multidisciplinary sciences
What problem does this paper attempt to address?